ANRO
Price
$17.16
Change
+$0.66 (+4.00%)
Updated
Jan 14 closing price
Capitalization
533.1M
64 days until earnings call
Intraday BUY SELL Signals
ETHZ
Price
$5.41
Change
+$0.26 (+5.05%)
Updated
Jan 14 closing price
Capitalization
102.67M
Intraday BUY SELL Signals
Interact to see
Advertisement

ANRO vs ETHZ

Header iconANRO vs ETHZ Comparison
Open Charts ANRO vs ETHZBanner chart's image
Alto Neuroscience
Price$17.16
Change+$0.66 (+4.00%)
Volume$160.77K
Capitalization533.1M
ETHZilla
Price$5.41
Change+$0.26 (+5.05%)
Volume$866.45K
Capitalization102.67M
ANRO vs ETHZ Comparison Chart in %
ANRO
Daily Signal:
Gain/Loss:
ETHZ
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ANRO vs. ETHZ commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANRO is a Hold and ETHZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (ANRO: $17.16 vs. ETHZ: $5.41)
Brand notoriety: ANRO and ETHZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANRO: 44% vs. ETHZ: 93%
Market capitalization -- ANRO: $533.1M vs. ETHZ: $102.67M
ANRO [@Biotechnology] is valued at $533.1M. ETHZ’s [@Biotechnology] market capitalization is $102.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANRO’s FA Score shows that 1 FA rating(s) are green whileETHZ’s FA Score has 0 green FA rating(s).

  • ANRO’s FA Score: 1 green, 4 red.
  • ETHZ’s FA Score: 0 green, 5 red.
According to our system of comparison, ANRO is a better buy in the long-term than ETHZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANRO’s TA Score shows that 4 TA indicator(s) are bullish while ETHZ’s TA Score has 6 bullish TA indicator(s).

  • ANRO’s TA Score: 4 bullish, 4 bearish.
  • ETHZ’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, ETHZ is a better buy in the short-term than ANRO.

Price Growth

ANRO (@Biotechnology) experienced а +7.25% price change this week, while ETHZ (@Biotechnology) price change was +8.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

ANRO is expected to report earnings on Mar 20, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANRO($533M) has a higher market cap than ETHZ($103M). ETHZ YTD gains are higher at: 10.408 vs. ANRO (-3.596). ANRO has higher annual earnings (EBITDA): -59.36M vs. ETHZ (-216.47M). ANRO has more cash in the bank: 138M vs. ETHZ (53.3M). ANRO has less debt than ETHZ: ANRO (27.5M) vs ETHZ (547M). ETHZ has higher revenues than ANRO: ETHZ (4.11M) vs ANRO (0).
ANROETHZANRO / ETHZ
Capitalization533M103M517%
EBITDA-59.36M-216.47M27%
Gain YTD-3.59610.408-35%
P/E RatioN/AN/A-
Revenue04.11M-
Total Cash138M53.3M259%
Total Debt27.5M547M5%
FUNDAMENTALS RATINGS
ETHZ: Fundamental Ratings
ETHZ
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANROETHZ
RSI
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
71%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 3 days ago
87%
Declines
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANRO
Daily Signal:
Gain/Loss:
ETHZ
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GUXPX5.540.05
+0.91%
Gabelli Utilities C
DRDAX25.100.11
+0.44%
Dearborn Partners Rising Dividend A
RYTSX59.67-0.30
-0.50%
Rydex Transportation A
RYSPX101.85-0.55
-0.54%
Rydex S&P 500 H
JHBCX65.40-0.96
-1.45%
JHancock Blue Chip Growth NAV

ANRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANRO has been loosely correlated with NUVL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ANRO jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANRO
1D Price
Change %
ANRO100%
+4.00%
NUVL - ANRO
35%
Loosely correlated
+6.59%
IMTX - ANRO
34%
Loosely correlated
+4.80%
ETHZ - ANRO
34%
Loosely correlated
+5.05%
IPSC - ANRO
33%
Poorly correlated
-6.05%
KOD - ANRO
33%
Poorly correlated
+1.24%
More

ETHZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETHZ has been loosely correlated with PTN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ETHZ jumps, then PTN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETHZ
1D Price
Change %
ETHZ100%
+5.05%
PTN - ETHZ
52%
Loosely correlated
-2.27%
JSPR - ETHZ
41%
Loosely correlated
+3.85%
PRQR - ETHZ
38%
Loosely correlated
N/A
REPL - ETHZ
34%
Loosely correlated
-4.10%
ANRO - ETHZ
34%
Loosely correlated
+4.00%
More